Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy

Status:
RECRUITING

Trial end date:
2026-03-01

Target enrollment:

Participant gender:

A Study of STM-416p Administered Intraoperatively to Patients Undergoing Radical Prostatectomy

PHASE1

SURGE Therapeutics